ALDR

Alder Biopharmaceuticals, Inc.
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

124 hedge funds and large institutions have $733M invested in Alder Biopharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 22 closing their positions.

Holders
124
Holders Change
-4
Holders Change %
-3.13%
% of All Funds
2.77%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
18
Increased
39
Reduced
36
Closed
22
Calls
$253K
Puts
$673K
Net Calls
-$420K
Net Calls Change
+$2.28M
Name Market Value Shares Shares
Change
Shares
Change %
Nomura Holdings
126
Nomura Holdings
Japan
-36,500 Closed
ARTA
127
A.R.T. Advisors
New York
-31,739 Closed
NA
128
Neuburgh Advisers
California
-25,568 Closed
FCM
129
Flinton Capital Management
Pennsylvania
-21,056 Closed
Principal Financial Group
130
Principal Financial Group
Iowa
-20,904 Closed
TAM
131
Tyers Asset Management
Texas
-16,544 Closed
PIM
132
Partner Investment Management
California
-15,886 Closed
GHCM
133
Glen Harbor Capital Management
California
-12,032 Closed
WAM
134
Weiss Asset Management
Massachusetts
-10,882 Closed
Pacer Advisors
135
Pacer Advisors
Pennsylvania
-7,073 Closed
CWM
136
Cornerstone Wealth Management
Missouri
-4,980 Closed
OTC
137
Opera Trading Capital
France
-2,990 Closed
Russell Investments Group
138
Russell Investments Group
United Kingdom
-2,200 Closed
RCM
139
Riverhead Capital Management
Delaware
-1,825 Closed
KF
140
Krilogy Financial
Missouri
-200 Closed
Federated Hermes
141
Federated Hermes
Pennsylvania
-35 Closed
WAM
142
Wolverine Asset Management
Illinois
GWS
143
Glassman Wealth Services
Virginia
$0 26
CFGS
144
Concourse Financial Group Securities
Alabama
GRP
145
Global Retirement Partners
California
$0 45
MOS
146
MGO One Seven
Ohio
$0 22 +22 New
GT
147
Glenmede Trust
Pennsylvania
$0 31 +31 New
PFO
148
Pathstone Family Office
New Jersey
$0 42 +42 New